Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Diabetes, Metabolic Syndrome and Obesity
Volume 12, 2019 - Issue
Review
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Ioannis Avgerinos1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
https://orcid.org/0000-0003-2232-1342
https://orcid.org/0000-0003-2232-1342, Aris Liakos1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greecehttps://orcid.org/0000-0003-3261-2979
https://orcid.org/0000-0003-3261-2979, Apostolos Tsapas1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;3 Harris Manchester College, University of Oxford, Oxford, UKhttps://orcid.org/0000-0003-0221-4072
https://orcid.org/0000-0003-0221-4072 & Eleni Bekiari1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greecehttps://orcid.org/0000-0001-9975-3835
https://orcid.org/0000-0001-9975-3835